Wednesday, June 10

Browsing: uHCC

Survivors

Camrelizumab Plus Rivoceranib/TACE Improve PFS, Increases Toxicity in uHCC

By NewsCancerJune 3, 20260

Camrelizumab plus rivoceranib and transarterial chemoembolization (TACE) improved progression-free survival (PFS), overall response rate (ORR), and exhibited a favorable overall…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

Browsing: uHCC

Camrelizumab Plus Rivoceranib/TACE Improve PFS, Increases Toxicity in uHCC

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Latest Post

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

Subscribe to Updates

What's Hot

Browsing: uHCC